JATT II Acquisition Corp (NASDAQ:JATT) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock (PIPE) Announced: US$225M · US$10 a share · Guggenheim Securities +2 Dealers: Guggenheim Securities, Cantor, LifeSci Capital Buyers: Access Biotechnology (Leads the PIPE as founding investor); Bain Capital Life Sciences; Deep Track Capital; RA Capital Management; Janus Henderson Investors; Vianti Capital; Farallon Capital Management Use of proceeds: Fund TALA-125 through a Phase 2b proof-of-concept study data readout in the second half of 2028 | Jun 29, 2026 |
| Public offering of ordinary shares Closed: US$60M raised · US$10 a share · Guggenheim Securities, LLC Dealers: Guggenheim Securities, LLC (lead) | Apr 20, 2026 |